Anaphylactoid reactions to radiocontrast media

Area of Science:

• Radiology
• Immunology
• Pharmacology

Background:

• Diagnostic and therapeutic contrast-enhanced imaging is increasingly utilized.
• Radiocontrast-mediated anaphylactoid reactions (RMAH) are a significant clinical concern.
• Understanding RMAH epidemiology, mechanisms, risk factors, and pretreatment is pertinent.

Purpose of the Study:

• To review the epidemiology, mechanisms, risk factors, and pretreatment strategies for RMAH.
• To highlight the evolution of contrast media and its impact on reaction rates.
• To provide guidance for managing high-risk patients requiring contrast administration.

Main Methods:

• Literature review and synthesis of current data on RMAH.
• Analysis of historical and current contrast media formulations (ionic, high-osmolality vs. nonionic, low-osmolality).
• Evaluation of patient-specific risk factors and established pretreatment protocols.

Main Results:

• The precise mechanisms of early and late RMAH remain incompletely understood, suggesting a multifactorial pathogenesis.
• Transition from high-osmolality to low-osmolality contrast media has reduced reaction incidence.
• Adverse responses occur in 1-12% of patients, varying by contrast type and patient characteristics.
• Effective pretreatment guidelines exist for high-risk individuals.

Conclusions:

• Despite advancements in contrast media, RMAH remain a relevant clinical issue.
• Risk stratification and appropriate pretreatment are essential for patient safety in contrast-enhanced imaging.
• Further research is needed to fully elucidate RMAH mechanisms.